Literature DB >> 21047877

Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study.

Guido Grassi1, Renata Cifkova, Stephane Laurent, Krzysztof Narkiewicz, Joseph Redon, Csaba Farsang, Margus Viigimaa, Serap Erdine, Gianmaria Brambilla, Michele Bombelli, Raffaella Dell'Oro, Massimo Notari, Giuseppe Mancia.   

Abstract

AIMS: Limited information is available on office and ambulatory blood pressure (BP) control as well as on cardiovascular (CV) risk profile in treated hypertensive patients living in central and eastern European countries. METHODS AND
RESULTS: In 2008, a survey on 7860 treated hypertensive patients followed by non-specialist or specialist physicians was carried out in nine central and eastern European countries (Albania, Belarus, Bosnia, Czech Republic, Latvia, Romania, Serbia, Slovakia, and Ukraine). Cardiovascular risk assessment was based on personal history, clinic BP values, as well as target organ damage evaluation. Patients had a mean (±SD) age of 60.1 ± 11 years, and the majority of them (83.5%) were followed by specialists. Average clinic BP was 149.3 ± 17/88.8 ± 11 mmHg. About 70% of patients displayed a very high-risk profile. Electrocardiogram was performed in 99% of patients, echocardiography in 65%, carotid ultrasound in 24%, fundoscopy in 68%, and search for microalbuminuria in 10%. Ambulatory BP monitoring was performed in about one-fifth of the recruited patients. Despite the widespread use of combination treatment (87% of the patients), office BP control (<140/90 mmHg) was achieved in 27.1% only, the corresponding control rate for ambulatory BP (<130/80 mmHg) being 35.7%. Blood pressure control was (i) variable among different countries, (ii) worse for systolic than for diastolic BP, (iii) slightly better in patients followed by specialists than by non-specialists, (iv) unrelated to patients' age, and (v) more unsatisfactory in high-risk hypertensives and in patients with coronary heart disease, stroke, or renal failure.
CONCLUSION: These data provide evidence that in central and eastern European countries office and ambulatory BP control are unsatisfactory, particularly in patients at very high CV risk, and not differ from that seen in Western Europe. They also show that assessment of subclinical organ damage is quite common, except for microalbuminuria, and that combination drug treatment is frequently used.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047877     DOI: 10.1093/eurheartj/ehq394

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  20 in total

1.  HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.

Authors:  Gino Seravalle; Nevrez Koylan; Istemi Nalbantgil; Nail Caglar; Fosca Quarti-Trevano; Wim Makel; Guido Grassi; Francesco Fici
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-22

2.  Lack of blood pressure control in Italy: room for improvement?

Authors:  M Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-12-03

3.  Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.

Authors:  F Fici; G Seravalle; N Koylan; I Nalbantgil; N Cagla; Y Korkut; F Quarti-Trevano; W Makel; G Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-11

Review 4.  Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts.

Authors:  M Bombelli; Rita Facchetti; Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2018-07-26       Impact factor: 5.369

Review 5.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

6.  Synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats.

Authors:  Yan-Ling Yang; Li-Ting Yu; Zhao-Tang Wu; Jian-Guang Yu; Jing-Ming Zhang; Qing-Hua Chen; Yong-Chu Bao; Jian-Guo Liu
Journal:  CNS Neurosci Ther       Date:  2012-06       Impact factor: 5.243

Review 7.  Role of ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Guido Grassi; Michele Bombelli; Gino Seravalle; Gianmaria Brambilla; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

8.  Trends in incidence of hypertension in Chinese adults, 1991-2009: the China Health and Nutrition Survey.

Authors:  Yajun Liang; Ruijuan Liu; Shufa Du; Chengxuan Qiu
Journal:  Int J Cardiol       Date:  2014-05-02       Impact factor: 4.164

9.  Blood pressure control and cardiovascular risk profile in hypertensive patients under specialist care in Argentina: Results from the CHARTER study.

Authors:  Marcos Marín; Jessica Barochiner; Pablo Rodríguez; Nicolás Renna; Carlos Castellaro; Walter Espeche; Alejandro De Cerchio; Mildren Del Sueldo; Sergio Vissani; Judith Zilberman
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-03       Impact factor: 3.738

Review 10.  Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.

Authors:  Ivo Abraham; Karen MacDonald; Christine Hermans; Ann Aerts; Christopher Lee; Heidi Brié; Stefaan Vancayzeele
Journal:  Vasc Health Risk Manag       Date:  2011-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.